J.P. Morgan Remains a Sell on Shanghai Junshi Biosciences Co., Ltd. Class H (1877)
I'm PortAI, I can summarize articles.
According to TipRanks, Huang is a 5-star analyst with an average return of 36.9% and a 67.57% success rate. Huang covers the Healthcare sector, focusing on stocks such as Innovent Biologics, Wuxi Biologics (Cayman), and Hangzhou Tigermed Consulting Co., Ltd. Class H. The word on The Street in general, suggests a Hold analyst consensus rating for Shanghai Junshi Biosciences Co., Ltd. Class H with a HK$30.56 average price target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments